Cytocom, Inc.
CBLI · NASDAQ
6/30/2021 | 3/31/2021 | 12/31/2020 | 9/30/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $13,777 | $14,359 | $1,946 | $2,721 |
| Short-Term Investments | $0 | $264 | $325 | $314 |
| Receivables | $0 | $0 | $12 | $135 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $47 | $70 | $32 | $55 |
| Total Curr. Assets | $13,824 | $14,694 | $2,314 | $3,225 |
| Property Plant & Equip (Net) | $5 | $6 | $4 | $6 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $5 | $6 | $4 | $6 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $13,829 | $14,700 | $2,318 | $3,231 |
| Liabilities | – | – | – | – |
| Payables | $61 | $310 | $168 | $281 |
| Short-Term Debt | $0 | $0 | $2,125 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $7 |
| Other Curr. Liab. | $0 | $208 | -$1,989 | $196 |
| Total Curr. Liab. | $301 | $518 | $305 | $484 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $301 | $518 | $305 | $484 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $77 | $77 | $67 | $65 |
| Retained Earnings | -$170,302 | -$169,642 | -$169,104 | -$168,409 |
| AOCI | -$682 | -$691 | -$686 | -$1,000 |
| Other Equity | $179,476 | $179,475 | $171,736 | $172,092 |
| Total Equity | $13,528 | $9,220 | $2,013 | $2,747 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $13,829 | $9,738 | $2,318 | $3,231 |
| Net Debt | -$13,777 | -$14,359 | $179 | -$2,721 |